Adolescent Metabolic/Bariatric Surgery: Effects on Obesity, Comorbidities, and Insulin Resistance

Daniel S. Hsia*, Amy Sanghavi Shah, Thomas Inge

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter


The high prevalence of severe obesity and data demonstrating childhood obesity tracks into adulthood suggest that these adolescents are at high risk to develop obesity-related comorbidities—such as insulin resistance, type 2 diabetes, obstructive sleep apnea, polycystic ovarian syndrome, fatty liver disease, and cardiovascular disease—by young adulthood. Diet, exercise, and behavior modification have limited success in providing significant and durable weight loss, while pharmacological therapy is currently limited in the pediatric population. Metabolic/bariatric surgery (MBS) in the adolescent population is emerging as an effective long-term option, as it results in sustained weight loss and improves obesity-related comorbidities. This chapter will review common MBS procedures, the indications for use, and the effects of surgery on obesity, associated comorbidities, and insulin resistance in adolescents.

Original languageEnglish (US)
Title of host publicationContemporary Endocrinology
PublisherHumana Press Inc.
Number of pages12
StatePublished - 2020
Externally publishedYes

Publication series

NameContemporary Endocrinology
ISSN (Print)2523-3785
ISSN (Electronic)2523-3793


  • Adjustable gastric banding
  • Adolescent
  • Cardiovascular disease
  • Fatty liver disease
  • Insulin resistance
  • Metabolic/bariatric surgery
  • Obstructive sleep apnea
  • Polycystic ovarian syndrome
  • Roux-en-Y gastric bypass
  • Type 2 diabetes
  • Vertical sleeve gastrectomy

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'Adolescent Metabolic/Bariatric Surgery: Effects on Obesity, Comorbidities, and Insulin Resistance'. Together they form a unique fingerprint.

Cite this